1887
1 - The 3rd Annual International Conference on Information and Sciences
  • ISSN: 1999-7086
  • EISSN: 1999-7094

Abstract

Placental adhesion disorder, or placenta accreta, is caused by a decidua basalis shortage that leads to the chorionic villi penetrating the myometrium. Different types of placental adhesion disorders are classified according to the degree of uterine adhesion. Cesarean Hysterectomy is indicated in cases of morbid adherence of the placenta in various age groups during childbearing age.

Evaluation of the influence of placental adhesion on hysterectomy at the time of cesarean in near-missed pregnant women and assessment of factors that increase its incidence among Iraqi women.

This research encompassed a case-control study involving 64 pregnant women, with the participants selected from Al-Yarmouk Teaching Hospital. The pregnant patients were divided into two groups. The first group consisted of thirty-two pregnant women with emergency cesarean hysterectomy due to placental adhesion. The second group was made up of thirty-two pregnant women with elective cesarean hysterectomy due to placental adhesion.

In the present study, it has been found that there are no significant differences in the age of patients who undergo elective cesarean hysterectomy as compared to emergency cesarean hysterectomy (p > 0.05). Also, according to the gestational age, most elective surgery patients are full-term pregnancies; meanwhile, the emergency cases are mostly preterm. Elective patient parity was higher than emergency cases at three parity 13 vs 9. The patients with emergency cesarean hysterectomy showed that the presence of two or more scars in the uterus was accreta in about 72% of patients. Meanwhile, the elective patients with placental adherence showed a higher frequency of two or more scars, the same as observed in emergency cases. Still, there were more emergency cases than elective cases.

There are elevations in the incidences of placental adhesion, reflecting the increase in cesarean hysterectomy surgeries and near-miss cases.

Loading

Article metrics loading...

/content/journals/10.5339/jemtac.2024.cism.7
2024-01-25
2024-07-12
Loading full text...

Full text loading...

/deliver/fulltext/jemtac/2024/1/jemtac.2024.cism.7.html?itemId=/content/journals/10.5339/jemtac.2024.cism.7&mimeType=html&fmt=ahah

References

  1. Jauniaux E, Chantraine F, Silver RM, Langhoff-Roos J. FIGO Placenta Accreta Diagnosis and Management Expert Consensus Panel. FIGO consensus guidelines on placenta accreta spectrum disorders: epidemiology. Int J Gynaecol Obstet. 2018; 140::265–273. doi: 10.1002/ijgo.12407.
    [Google Scholar]
  2. Jauniaux E, Collins S, Burton GJ. Placenta accrete spectrum: pathophysiology and evidence-based anatomy for prenatal ultrasound imaging. Am J Obstet Gynecol. 2018; 218::75–87. doi: 10.1016/j.ajog.2017.05.067.
    [Google Scholar]
  3. Cahill AG, Beigi R, Heine RP, Silver RM, Wax JR. Society of Gynecologic Oncology; American College of Obstetricians and Gynecologists; and the Society for Maternal–Fetal Medicine. Placenta accreta spectrum. Am J Obstet Gynecol. 2018; 219::B2–B16. doi: 10.1016/j.ajog.2018.09.042.
    [Google Scholar]
  4. Bourgioti C, Zafeiropoulou K, Fotopoulos S, Nikolaidou ME, Antoniou A, Tzavara C, et al. MRI Features Predictive of Invasive Placenta With Extrauterine Spread in High-Risk Gravid Patients: A Prospective Evaluation. AJR Am J Roentgenol. 2018 Sep; 211:(3):701–11. doi: 10.2214/AJR.17.19303.
    [Google Scholar]
  5. Burke WM, Orr J, Leitao M, Salom E, Gehrig P, Olawaiye AB, et al. Endometrial cancer: a review and current management strategies: part I. Gynecol Oncol. 2014 Aug; 134:(2):385–92. doi: 10.1016/j.ygyno.2014.05.018.
    [Google Scholar]
  6. Wright JD, Herzog TJ, Tsui J, Ananth CV, Lewin SN, Lu YS, et al. Nationwide trends in the performance of inpatient hysterectomy in the United States. Obstet Gynecol. 2013 Aug; 122:(2 Pt 1):233-241. doi: 10.1097/AOG.0b013e318299a6cf.
    [Google Scholar]
  7. Familiari A, Liberati M, Lim P, Pagani G, Cali G, Buca D, et al. Diagnostic accuracy of magnetic resonance imaging in detecting the severity of abnormal invasive placenta: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018 May; 97:(5):507–520. doi: 10.1111/aogs.13258.
    [Google Scholar]
  8. Chen X, Shan R, Zhao L, Song Q, Zuo C, Zhang X, et al. Invasive placenta previa: placental bulge with distorted uterine outline and uterine serosal hypervascularity at 1.5T MRI - useful features for differentiating placenta percreta from placenta accreta. Eur Radiol. 2017; 28:(2):708–717. doi: 10.1007/s00330-017-4980-z.
    [Google Scholar]
  9. Clark HR, Ng TW, Khan A, Happe S, Dashe J, Xi Y, et al. Placenta Accreta Spectrum: Correlation of MRI Parameters With Pathologic and Surgical Outcomes of High-Risk Pregnancies. AJR Am J Roentgenol. 2020 Jun; 214:(6):1417–1423. doi: 10.2214/AJR.19.21705.
    [Google Scholar]
  10. Kilcoyne A, Shenoy-Bhangle AS, Roberts DJ, Sisodia RC, Gervais DA, Lee SI. MRI of Placenta Accreta, Placenta Increta, and Placenta Percreta: Pearls and Pitfalls. AJR Am J Roentgenol. 2017 Jan; 208:(1):214–221. doi: 10.2214/AJR.16.16281.
    [Google Scholar]
  11. Morel O, Collins SL, Uzan-Augui J, Masselli G, Duan J, Chabot-Lecoanet AC, et al. A proposal for standardized magnetic resonance imaging (MRI) descriptors of abnormally invasive placenta (AIP) - From the International Society for AIP. Diagn Interv Imaging. 2019 Jun; 100:(6):319–325. doi: 10.1016/j.diii.2019.02.004.
    [Google Scholar]
  12. Wu S, Kocherginsky M, Hibbard JU. Abnormal placentation: twenty-year analysis. Am J Obstet Gynecol. 2005 May; 192:(5):1458–61. doi: 10.1016/j.ajog.2004.12.074.
    [Google Scholar]
  13. Jha P, Pōder L, Bourgioti C, Bharwani N, Lewis S, Kamath A, et al. Society of Abdominal Radiology (SAR) and European Society of Urogenital Radiology (ESUR) joint consensus statement for MR imaging of placenta accreta spectrum disorders. Eur Radiol. 2020 May; 30:(5):2604–2615. doi: 10.1007/s00330-019-06617-7.
    [Google Scholar]
  14. Abotorabi S, Chamanara S, Oveisi S, Rafiei M, Amini L. Effects of Placenta Location in Pregnancy Outcomes of Placenta Accreta Spectrum (PAS): A Retrospective Cohort Study. J Family Reprod Health. 2021 Dec; 15:(4):229–235. doi: 10.18502/jfrh.v15i4.7888.
    [Google Scholar]
  15. Zosmer N, Jauniaux E, Bunce C, Panaiotova J, Shaikh H, Nicholaides KH. Interobserver agreement on standardized ultrasound and histopathologic signs for the prenatal diagnosis of placenta accreta spectrum disorders. Int J Gynaecol Obstet. 2018 Mar; 140:(3):326–331. doi: 10.1002/ijgo.12389.
    [Google Scholar]
  16. Agostini TCF, Figueiredo R, Warmbrand G, Torres US, Pria HRFD, D’Ippolito G. Placental adhesion disorder: magnetic resonance imaging features and a proposal for a structured report. Radiol Bras. 2020 Sep-Oct; 53:(5):329-336. doi: 10.1590/0100-3984.2019.0037.
    [Google Scholar]
  17. Pagani G, Cali G, Acharya G, Trisch IT, Palacios-Jaraquemada J, Familiari A, et al. Diagnostic accuracy of ultrasound in detecting the severity of abnormally invasive placentation: a systematic review and meta-analysis. Acta Obstet Gynecol Scand. 2018 Jan; 97:(1):25–37. doi: 10.1111/aogs.13238.
    [Google Scholar]
  18. Iacovelli A, Liberati M, Khalil A, Timor-Trisch I, Leombroni M, Buca D, et al. Risk factors for abnormally invasive placenta: a systematic review and meta-analysis. J Matern Fetal Neonatal Med. 2020 Feb; 33:(3):471–481. doi: 10.1080/14767058.2018.1493453.
    [Google Scholar]
  19. Shainker SA, Coleman B, Timor-Tritsch IE, Bhide A, Bromley B, Cahill AG, et al. Special Report of the Society for Maternal-Fetal Medicine Placenta Accreta Spectrum Ultrasound Marker Task Force: Consensus on definition of markers and approach to the ultrasound examination in pregnancies at risk for placenta accreta spectrum. Am J Obstet Gynecol. 2021 Jan; 224:(1):B2-B14. doi: 10.1016/j.ajog.2020.09.001.
    [Google Scholar]
  20. Taye LR, Basumatari B Sr, Das MC, Mahanta P Sr. Ultrasonographical Evaluation of Placenta Previa in Scarred and Unscarred Uterus in a Tertiary Care Centre. Cureus. 2023 Jul 27; 15:(7):e42586. doi: 10.7759/cureus.42586.
    [Google Scholar]
  21. Bailit JL, Grobman WA, Rice MM, Reddy UM, Wapner RJ, Varner MW, et al. Morbidly adherent placenta treatments and outcomes. Obstet Gynecol. 2015 Mar; 125:(3):683–689. doi: 10.1097/AOG.0000000000000680.
    [Google Scholar]
  22. Bartels HC, Postle JD, Downey P, Brennan DJ. Placenta Accreta Spectrum: A Review of Pathology, Molecular Biology, and Biomarkers. Dis Markers. 2018 Jul 3; 2018::1507674. doi: 10.1155/2018/1507674.
    [Google Scholar]
  23. Marcellin L, Delorme P, Bonnet MP, Grange G, Kayem G, Tsatsaris V, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018 Aug; 219:(2):193.e1-193.e9. doi: 10.1016/j.ajog.2018.04.049.
    [Google Scholar]
  24. Tantbirojn P, Crum CP, Parast MM. Pathophysiology of placenta creta: the role of decidua and extravillous trophoblast. Placenta. 2008 Jul; 29:(7):639–45. doi: 10.1016/j.placenta.2008.04.008.
    [Google Scholar]
  25. Shamshirsaz AA, Fox KA, Salmanian B, Diaz-Arrastia CR, Lee W, Baker BW, et al. Maternal morbidity in patients with morbidly adherent placenta treated with and without a standardized multidisciplinary approach. Am J Obstet Gynecol. 2015 Feb; 212:(2):218.e1-9. doi: 10.1016/j.ajog.2014.08.019.
    [Google Scholar]
/content/journals/10.5339/jemtac.2024.cism.7
Loading
/content/journals/10.5339/jemtac.2024.cism.7
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error